Skip to main content

Table 9 Performance comparison among various gene sets

From: Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data

Gene set Training Acc (%) Training Asurv (%) Test Acc (%)
32-gene (lung cancer related) 65.38 34.47 50.00 (13/26)
9-gene (SBS from the 32-gene set) 73.07 55.70 80.76 (21/26)
16-gene (EMT related, SVM ensemble) 93.59 74.81 76.92 (20/26)
11-gene (EMT and cancer related) 87.18 53.37 69.23 (18/26)
5-gene (EMT and lung cancer related) 78.25 52.33 76.92 (20/26)
1-gene (CCL16, maximum Acc) 74.36 43.58 57.69 (15/26)
1-gene (CDKN2AIP, maximum Asurv) 61.54 46.00 76.92 (20/26)
  1. The value of Asurv is 73.21% for real classes of samples in the training dataset.